What is the difference between ESCITALOPRAM ORAL and PAROXETINE HYDROCHLORIDE HEMIHYDRATE?

ESCITALOPRAM ORAL and PAROXETINE HYDROCHLORIDE HEMIHYDRATE are both SSRIs, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can ESCITALOPRAM ORAL and PAROXETINE HYDROCHLORIDE HEMIHYDRATE be used for the same conditions?

Both medications are prescribed for overlapping indications including due to AbbVie Inc.’s marketing exclusivity rights. Always verify with your prescriber and the current FDA label before switching.

Is Escitalopram Oral Solution the same as Paroxetine?

No. Escitalopram Oral Solution (ESCITALOPRAM ORAL) and Paroxetine (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ESCITALOPRAM ORAL or PAROXETINE HYDROCHLORIDE HEMIHYDRATE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ESCITALOPRAM ORAL to PAROXETINE HYDROCHLORIDE HEMIHYDRATE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ESCITALOPRAM ORAL vs PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Compare ESCITALOPRAM ORAL (Escitalopram Oral Solution) and PAROXETINE HYDROCHLORIDE HEMIHYDRATE (Paroxetine) — clinical data, side effects, and patient experiences.

ESCITALOPRAM ORAL

Escitalopram Oral Solution · SSRI

How it works

Other agent

Approved for

due to AbbVie Inc.’s marketing exclusivity rights

OralTablet

PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Paroxetine · SSRI

How it works

12.1 Mechanism of Action The mechanism of action of paroxetine tablets in the treatment of MDD, SAD, OCD, PD, GAD, and PTSD is unknown, but is presumed to be linked to potentiation...

Approved for

See full prescribing information

OralTablet

Quick Comparison

ESCITALOPRAM ORALPAROXETINE HYDROCHLORIDE HEMIHYDRATE

Drug Class

SSRI

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ESCITALOPRAM ORAL

Fatigue

1-10%

Nausea

1-10%

Drug Not Working

1-10%

Headache

1-10%

Diarrhea

1-10%

Anxiety

1-10%

Dizziness

1-10%

Depression

1-10%

PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Drug Not Working

1-10%

Nausea

1-10%

Dizziness

1-10%

Anxiety

1-10%

Fatigue

1-10%

Headache

1-10%

Depression

1-10%

Insomnia

1-10%

FDA Warnings

ESCITALOPRAM ORAL

5 WARNINGS AND PRECAUTIONS Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone
6 ) Increased Risk of Bleeding: Concomitant use of nonsteroidal anti-inflammatory drugs, aspirin, other antiplatelet drugs, warfarin and other drugs that affect coagulation may increase risk ( 5
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied
There were differences in absolute risk of suicidal thoughts and behaviors across the different indications, with the highest incidence in patients with MDD

PAROXETINE HYDROCHLORIDE HEMIHYDRATE

5 WARNINGS AND PRECAUTIONS Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone
Meta-analyses of epidemiological studies have shown increased risk (less than 2-fold) of cardiovascular malformations with exposure during the first trimester
1 ) Increased Risk of Bleeding : Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, other antiplatelet drugs, warfarin, and other anticoagulant drugs may increase risk
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied

Clinical Trial Data

No head-to-head clinical studies found for ESCITALOPRAM ORAL vs PAROXETINE HYDROCHLORIDE HEMIHYDRATE.

ESCITALOPRAM ORAL vs PAROXETINE HYDROCHLORIDE HEMIHYDRATE: What You Should Know

Key Differences

Both ESCITALOPRAM ORAL and PAROXETINE HYDROCHLORIDE HEMIHYDRATE belong to the SSRI class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

ESCITALOPRAM ORAL carries 4 FDA warnings. PAROXETINE HYDROCHLORIDE HEMIHYDRATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ESCITALOPRAM ORAL vs PAROXETINE→ESCITALOPRAM ORAL vs SERTRALINE HCL→ESCITALOPRAM ORAL vs SERTRALINE HYDROCHLORIDE→CITALOPRAM HYDROBROMIDE vs ESCITALOPRAM ORAL→ESCITALOPRAM ORAL vs FLUOXETINE HYDROCHLORIDE→ESCITALOPRAM ORAL vs FLUOXETINE HCL→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ESCITALOPRAM ORAL: DailyMed label · FAERS adverse events · ClinicalTrials.gov
PAROXETINE HYDROCHLORIDE HEMIHYDRATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ESCITALOPRAM ORAL vs PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Compare ESCITALOPRAM ORAL (Escitalopram Oral Solution) and PAROXETINE HYDROCHLORIDE HEMIHYDRATE (Paroxetine) — clinical data, side effects, and patient experiences.

ESCITALOPRAM ORAL

Escitalopram Oral Solution · SSRI

How it works

Other agent

Approved for

due to AbbVie Inc.’s marketing exclusivity rights

OralTablet

PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Paroxetine · SSRI

How it works

12.1 Mechanism of Action The mechanism of action of paroxetine tablets in the treatment of MDD, SAD, OCD, PD, GAD, and PTSD is unknown, but is presumed to be linked to potentiation...

Approved for

See full prescribing information

OralTablet

Quick Comparison

ESCITALOPRAM ORALPAROXETINE HYDROCHLORIDE HEMIHYDRATE

Drug Class

SSRI

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ESCITALOPRAM ORAL

Fatigue

1-10%

Nausea

1-10%

Drug Not Working

1-10%

Headache

1-10%

Diarrhea

1-10%

Anxiety

1-10%

Dizziness

1-10%

Depression

1-10%

PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Drug Not Working

1-10%

Nausea

1-10%

Dizziness

1-10%

Anxiety

1-10%

Fatigue

1-10%

Headache

1-10%

Depression

1-10%

Insomnia

1-10%

FDA Warnings

ESCITALOPRAM ORAL

5 WARNINGS AND PRECAUTIONS Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone
6 ) Increased Risk of Bleeding: Concomitant use of nonsteroidal anti-inflammatory drugs, aspirin, other antiplatelet drugs, warfarin and other drugs that affect coagulation may increase risk ( 5
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied
There were differences in absolute risk of suicidal thoughts and behaviors across the different indications, with the highest incidence in patients with MDD

PAROXETINE HYDROCHLORIDE HEMIHYDRATE

5 WARNINGS AND PRECAUTIONS Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone
Meta-analyses of epidemiological studies have shown increased risk (less than 2-fold) of cardiovascular malformations with exposure during the first trimester
1 ) Increased Risk of Bleeding : Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, other antiplatelet drugs, warfarin, and other anticoagulant drugs may increase risk
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied

Clinical Trial Data

No head-to-head clinical studies found for ESCITALOPRAM ORAL vs PAROXETINE HYDROCHLORIDE HEMIHYDRATE.

ESCITALOPRAM ORAL vs PAROXETINE HYDROCHLORIDE HEMIHYDRATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ESCITALOPRAM ORAL: DailyMed label · FAERS adverse events · ClinicalTrials.gov
PAROXETINE HYDROCHLORIDE HEMIHYDRATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov